Tech Landscape Research
Supplier Database
We track 4,083 solution providers in the global enterprise technology ecosystem. Our data supports our internal team and clients in conducting due diligence, mapping trends, and sourcing technology.
Case Study Database
We have catalogued 19,090 case studies to help our clients identify new solutions, evaluate technology maturity, and benchmark their peers.
Compare solutions and gain insights into tech adoption trends by analyzing real case studies.
Case studies are mapped to suppliers, use cases, and industries for easy reference. Quickly find and benchmark solutions based on your current needs.
Case studies are mapped to suppliers, use cases, and industries for easy reference. Quickly find and benchmark solutions based on your current needs.
Discover startup specialists and leading tech providers matching your requirements.
You can filter suppliers by more than 300 variables across technologies, industries, functions, use cases, country, revenue and more.
You can filter suppliers by more than 300 variables across technologies, industries, functions, use cases, country, revenue and more.
Gain access to detailed supplier profiles and compare multiple suppliers.
Download vendor profiles to support shortlisting and internal assessment of potential vendors.
Download vendor profiles to support shortlisting and internal assessment of potential vendors.
Our Innovation Insights
Latest Insights
Insights
Parallel Innovation: China’s Edge in Biopharma
Over the past decade, China has rapidly emerged as a powerhouse in pharmaceutical innovation. Behind this transformation lies a distinct operational strategy: parallel processing across the drug development lifecycle. Unlike the traditional linear model followed by most multinational companies, Chinese biopharma firms have institutionalized an approach that accelerates time-to-market by running clinical trials, regulatory submissions, manufacturing scale-up, and digital integration concurrently rather than sequentially. This Insight explores how Chinese pharmaceutical companies are running processes in parallel, what makes this system unique compared to global norms, and what multinational firms can learn from the China model.
Insights
Boosting Pharma Innovation Capacity in China
Multinational pharmaceutical companies are increasingly investing in China to build internal innovation capacity and / or forging external partnerships with Chinese pharma, driven by the country's robust biotech ecosystem, supportive government policies, and advancements in AI and data science.
Insights
Digital Silk Road: AI Exports Reshaping Global Tech Power
In the rapidly evolving landscape of global technology and geopolitics, China’s Digital Silk Road (DSR) has emerged as a pivotal extension of its Belt and Road Initiative (BRI), launched in 2015.
This initiative, initially focused on physical infrastructure, has shifted toward digital connectivity, with artificial intelligence (AI) at its core. By 2025, the DSR’s role in exporting AI technologies has become a critical lens for understanding China’s ambition to challenge the technological dominance of the U.S. and the EU while fostering economic and political ties with developing nations.
